Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

Contributed by: PR Newswire

Tags

Shanghai-CAR-T

More Like This

PR Newswire associated0

U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China

King Faisal Specialist Hospital and Research Centre Celebrates the Success of Treating 100 Patients with Lymphocytic Leukemia Using CAR T-Cells

Business Wire logo

CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 2030

JW Therapeutics Announces NMPA Approval of the Supplemental Biological License Application for Carteyva® in Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma

Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress

PR Newswire associated0

Abu Dhabi Stem Cells Center Successfully Manufactures UAE's First CAR-T Cell to Treat an 11-Year Old Leukemia Patient

After 35 Years with Parkinson's Disease and a Life-Threatening Infection, One Patient Reclaimed Independent Living

GlobeNewswire associated0

KFSHRC Successfully Produces the First Therapeutic T-Cells in the Kingdom

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us